Aref, Salah <br/><br/>
Clinicopathologic Effect of DNMT3A Mutation in Adult T-Cell Acute Lymphoblastic Leukemia.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  Jan 2016 
 - 43-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2015.11.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Aged<br/>Antibiotics, Antineoplastic--therapeutic use<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Consolidation Chemotherapy<br/>Cytarabine--therapeutic use<br/>DNA (Cytosine-5-)-Methyltransferases--genetics<br/>DNA Methyltransferase 3A<br/>Daunorubicin--therapeutic use<br/>Disease-Free Survival<br/>Egypt--epidemiology<br/>Female<br/>Humans<br/>Induction Chemotherapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--genetics<br/>Prognosis<br/>Sequence Analysis, DNA<br/>Young Adult